Glenmede Trust Co. NA Buys 2,655 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Glenmede Trust Co. NA grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.2% in the 3rd quarter, Holdings Channel reports. The firm owned 53,565 shares of the medical equipment provider’s stock after acquiring an additional 2,655 shares during the quarter. Glenmede Trust Co. NA’s holdings in Intuitive Surgical were worth $26,315,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Soros Capital Management LLC acquired a new position in Intuitive Surgical in the third quarter valued at $5,158,000. Townsquare Capital LLC lifted its stake in shares of Intuitive Surgical by 41.4% in the 3rd quarter. Townsquare Capital LLC now owns 11,071 shares of the medical equipment provider’s stock valued at $5,439,000 after purchasing an additional 3,239 shares during the period. Baldwin Investment Management LLC boosted its position in shares of Intuitive Surgical by 1.6% during the 3rd quarter. Baldwin Investment Management LLC now owns 9,743 shares of the medical equipment provider’s stock valued at $4,786,000 after purchasing an additional 158 shares in the last quarter. Avestar Capital LLC boosted its position in shares of Intuitive Surgical by 3.8% during the 3rd quarter. Avestar Capital LLC now owns 4,675 shares of the medical equipment provider’s stock valued at $2,297,000 after purchasing an additional 170 shares in the last quarter. Finally, Brooklyn Investment Group grew its stake in Intuitive Surgical by 8.0% during the third quarter. Brooklyn Investment Group now owns 2,816 shares of the medical equipment provider’s stock worth $1,383,000 after purchasing an additional 208 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on ISRG shares. Robert W. Baird increased their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Piper Sandler reissued an “overweight” rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Leerink Partners upped their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $526.06.

Intuitive Surgical Stock Down 0.7 %

Shares of ISRG opened at $538.55 on Thursday. The business’s 50-day moving average price is $507.94 and its 200-day moving average price is $466.79. Intuitive Surgical, Inc. has a twelve month low of $304.50 and a twelve month high of $552.00. The stock has a market cap of $191.82 billion, a PE ratio of 86.58, a P/E/G ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $475.00, for a total transaction of $142,500.00. Following the completion of the transaction, the general counsel now owns 1,595 shares of the company’s stock, valued at approximately $757,625. The trade was a 15.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. This trade represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,459 shares of company stock worth $26,080,251 in the last ninety days. 0.80% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.